Effects of GLP-1RA and SGLT2i, Alone or in Combination, on Mouse Models of Type 2 Diabetes Representing Different Disease Stages

Glucagon-like peptide-1 receptor agonist (GLP-1RA) and sodium-dependent glucose transporter 2 inhibitor (SGLT2i), in addition to lowering glucose, have pleiotropic effects on the heart, kidneys, and liver. These drugs have thus come into widespread use for treating type 2 diabetes (T2DM). However, m...

Descripción completa

Detalles Bibliográficos
Autores principales: Koike, Masao, Saito, Hitoki, Kohno, Genta, Takubo, Masahiro, Watanabe, Kentaro, Ishihara, Hisamitsu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8583813/
https://www.ncbi.nlm.nih.gov/pubmed/34768897
http://dx.doi.org/10.3390/ijms222111463

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8583813/
https://www.ncbi.nlm.nih.gov/pubmed/34768897
http://dx.doi.org/10.3390/ijms222111463

Ejemplares similares